Unjha Formulations logo

Unjha Formulations

UNJHAFORMULATIONSLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹15.10 Cr
Volatility
Moderate
P/E Ratio
32.1
EBITDA
₹1.10 Cr
Return on Equity
18.34%
Debt to Equity
0
Book Value
₹8.58
EPS
₹1.78
52W High
₹36.38
52W Low
₹17.52

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

2
  • The company has delivered a poor sales growth of 9.37% over past five years.
  • Promoter holding is low: 36.9%

Growth Rate

Revenue Growth
12.14% higher than 3Y
Net Income Growth
75% higher than 3Y
Cash Flow Change
—
ROE
41.29% higher than 3Y
ROCE
47.96% higher than 3Y
EBITDA Margin (Avg.)
55.43% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.76
4.76
5.55
4.43
3.95
3.78
3.76
2.44
3.63
4.29
4.44
3.33
3.31
Expenses
3.54
4.87
5.14
4.37
3.23
3.89
3.52
2.7
3.21
3.5
4.16
3.78
3.12
Operating Profit
0.22
-0.11
0.41
0.06
0.72
-0.11
0.24
-0.26
0.42
0.79
0.28
-0.45
0.19
OPM %
5.85%
-2.31%
7.39%
1.35%
18.23%
-2.91%
6.38%
-10.66%
11.57%
18.41%
6.31%
-13.51%
5.74%
Other Income
-0.01
0.01
0
0.01
0
0.02
0.01
0
0
0.06
0
0
0
Interest
0.02
0
0
0.05
0
0
0
0
0
0
0
0
0
Depreciation
0
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.03
0.04
0.04
0.04
PBT
0.19
-0.12
0.39
0
0.7
-0.11
0.23
-0.29
0.39
0.82
0.24
-0.49
0.15
Tax %
0%
0%
0%
—
0%
0%
0%
41.38%
0%
0%
0%
51.02%
0%
Net Profit
0.18
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
-0.74
0.16
EPS in Rs
0.4
-0.27
0.87
-0.4
1.56
-0.25
0.49
-0.92
0.87
1.83
0.54
-1.65
0.36
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
8.84
10.36
12.23
11.3
11.28
10.59
9.96
14.16
13.15
18.5
13.86
15.59
15.37
Expenses
8.65
10
11.86
10.96
10.98
10.34
9.83
13.84
12.71
17.93
13.34
14.64
14.56
Operating Profit
0.19
0.36
0.37
0.34
0.3
0.25
0.13
0.32
0.44
0.57
0.52
0.95
0.81
OPM %
2.15%
3.47%
3.03%
3.01%
2.66%
2.36%
1.31%
2.26%
3.35%
3.08%
3.75%
6.09%
5.27%
Other Income
0.09
0.08
0.11
0.04
0.1
0.26
0.22
0.19
0.03
0.01
0.11
0.16
0.06
Interest
0.01
0.1
0.1
0.02
0.01
0.12
0.17
0.13
0.06
0.05
0.01
0.01
0
Depreciation
0.09
0.08
0.09
0.1
0.09
0.08
0.08
0.08
0.08
0.08
0.1
0.14
0.15
PBT
0.18
0.26
0.29
0.26
0.3
0.31
0.1
0.3
0.33
0.45
0.52
0.96
0.72
Tax %
0%
0%
0%
0%
0%
0%
0%
16.67%
15.15%
40%
23.08%
26.04%
—
Net Profit
0.17
0.26
0.3
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
0.7
0.48
EPS in Rs
0.38
0.58
0.67
0.58
0.67
0.69
0.22
0.56
0.62
0.62
0.92
1.56
1.08
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.48
4.48
4.48
4.48
4.48
4.48
4.48
4.48
4.48
4.48
4.48
4.48
Reserves
-4.09
-3.83
-3.54
-3.27
-2.97
-2.67
-2.56
-2.31
-2.03
-1.75
-1.34
-0.64
Borrowings
0.4
0
0.05
0
0
0
0
0
0
0
0
0
Other Liabilities
2.51
2.28
2.79
2.75
2.15
1.9
1.61
1.28
0.96
2.2
1.42
1.67
Total Liabilities
3.3
2.93
3.78
3.96
3.66
3.71
3.53
3.45
3.41
4.93
4.56
5.51
Fixed Assets
1.09
1.03
1.22
1.16
1.12
1.14
1.12
1.07
1.1
1.12
1.2
1.3
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
2.21
1.9
2.56
2.8
2.54
2.57
2.41
2.38
2.31
3.81
3.36
4.21
Total Assets
3.3
2.93
3.78
3.96
3.66
3.71
3.53
3.45
3.41
4.93
4.56
5.51
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.7
0.41
0.39
0.14
-0.12
0.39
-0.7
0.28
-0.26
1.03
-0.04
1.24
Investing
-0.09
-0.02
-0.28
0.06
0.04
-0.1
-0.06
-0.02
-0.1
-0.11
-0.18
-0.23
Financing
0.4
-0.4
0.05
-0.05
0.23
0
0
0
-0.06
-0.05
-0.01
-0.01
Net Cash Flow
-0.38
-0.01
0.15
0.15
0.16
0.29
-0.77
0.25
-0.42
0.86
-0.23
1
Free Cash Flow
-0.78
0.39
0.11
0.2
-0.08
0.29
-0.76
0.26
-0.36
0.92
-0.22
1.01
CFO/OP
-368
114
105
41
-37
204
-408
88
-48
189
19
156
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
28.08
28.54
19.4
25.19
43.36
39.64
35.91
18.04
29.14
31.76
39.77
31.61
Inventory Days
35.62
22.76
40.83
39.4
22.92
21.37
55.6
34.08
38.92
29.56
32.92
19.1
Days Payable
122
94.35
98.2
106
87.5
82.79
77.35
39.81
32.1
47.85
37.39
39.71
Cash Conversion Cycle
-58.78
-43.06
-37.97
-41.63
-21.22
-21.79
14.16
12.31
35.97
13.47
35.29
10.99
Working Capital Days
-46.66
-28.19
-24.17
-21.96
-8.41
-9.31
22.72
17.27
37.19
14.6
34.24
21.31
ROCE %
37.62%
50%
47.56%
25.45%
22.79%
25.9%
14.48%
21.03%
16.88%
19.31%
18.06%
27.79%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Unjha Formulations insights

62 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Public55.48%Others7.60%Promot.36.92%As ofJun 2026

Documents

Frequently Asked Questions about Unjha Formulations

What does Unjha Formulations Ltd do?
Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]
Where is Unjha Formulations Ltd (531762) listed?
Unjha Formulations Ltd trades as UNJHAFORMULATIONSLTD on the NSE and under code UNJHAFOR on the BSE.
Which sector does Unjha Formulations Ltd belong to?
Unjha Formulations Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Unjha Formulations Ltd?
Unjha Formulations Ltd has a market capitalisation of ₹15.1 Cr, which places it in the Small Cap band.
What is the PE ratio of Unjha Formulations Ltd?
Unjha Formulations Ltd trades at a PE ratio of 32.10, on earnings per share of ₹1.78, against a book value of ₹8.58 per share.
What is the 52-week high and low of Unjha Formulations Ltd?
Over the last 52 weeks Unjha Formulations Ltd has traded between ₹17.52 and ₹36.38.
What is the Return on Equity (ROE) of Unjha Formulations Ltd?
Unjha Formulations Ltd reported a return on equity of 18.34%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]

Website unjhaformulations.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531762.md for Unjha Formulations Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List